Q3 2022 EPS Estimates for Syneos Health, Inc. (NASDAQ:SYNH) Decreased by Jefferies Financial Group

Syneos Health, Inc. (NASDAQ:SYNHGet Rating) – Analysts at Jefferies Financial Group decreased their Q3 2022 EPS estimates for shares of Syneos Health in a report issued on Monday, April 25th. Jefferies Financial Group analyst D. Windley now anticipates that the company will post earnings of $1.14 per share for the quarter, down from their previous forecast of $1.24. Jefferies Financial Group currently has a “Hold” rating and a $75.00 price target on the stock. Jefferies Financial Group also issued estimates for Syneos Health’s FY2023 earnings at $4.92 EPS.

Syneos Health (NASDAQ:SYNHGet Rating) last announced its quarterly earnings data on Thursday, February 17th. The company reported $1.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.34 by $0.02. Syneos Health had a return on equity of 12.69% and a net margin of 4.50%. The firm had revenue of $1.37 billion during the quarter, compared to the consensus estimate of $1.40 billion. During the same quarter in the prior year, the company earned $1.00 EPS. The business’s revenue for the quarter was up 20.5% on a year-over-year basis.

Other analysts have also recently issued reports about the company. Mizuho cut their price target on Syneos Health from $109.00 to $94.00 and set a “buy” rating on the stock in a research note on Monday, March 7th. StockNews.com assumed coverage on shares of Syneos Health in a report on Thursday, March 31st. They set a “hold” rating for the company. Barclays reduced their price target on shares of Syneos Health from $115.00 to $105.00 and set an “overweight” rating for the company in a report on Thursday, January 27th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Syneos Health in a research note on Monday, April 11th. They set a “buy” rating and a $102.00 target price for the company. Finally, Zacks Investment Research upgraded shares of Syneos Health from a “sell” rating to a “hold” rating and set a $95.00 price target on the stock in a research note on Monday, January 17th. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $100.33.

NASDAQ SYNH opened at $72.57 on Tuesday. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.07 and a quick ratio of 1.07. The business has a 50 day simple moving average of $79.59 and a two-hundred day simple moving average of $89.34. The stock has a market capitalization of $7.44 billion, a PE ratio of 32.40 and a beta of 1.84. Syneos Health has a 1-year low of $70.07 and a 1-year high of $104.18.

Institutional investors have recently bought and sold shares of the company. Assenagon Asset Management S.A. boosted its holdings in shares of Syneos Health by 622.6% during the first quarter. Assenagon Asset Management S.A. now owns 129,692 shares of the company’s stock worth $10,499,000 after purchasing an additional 111,744 shares during the last quarter. Louisiana State Employees Retirement System boosted its holdings in Syneos Health by 1.9% during the first quarter. Louisiana State Employees Retirement System now owns 27,200 shares of the company’s stock valued at $2,211,000 after acquiring an additional 500 shares during the period. Artemis Investment Management LLP raised its position in Syneos Health by 1.0% in the first quarter. Artemis Investment Management LLP now owns 1,171,275 shares of the company’s stock worth $94,711,000 after purchasing an additional 11,869 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Syneos Health by 4.3% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 19,628 shares of the company’s stock worth $1,589,000 after buying an additional 808 shares during the last quarter. Finally, Virginia Retirement Systems ET AL grew its stake in shares of Syneos Health by 29.1% during the first quarter. Virginia Retirement Systems ET AL now owns 23,100 shares of the company’s stock valued at $1,870,000 after purchasing an additional 5,200 shares during the last quarter. Institutional investors and hedge funds own 94.63% of the company’s stock.

In other news, CAO Donna Hildebrand Kralowetz sold 1,055 shares of the firm’s stock in a transaction that occurred on Monday, January 31st. The shares were sold at an average price of $90.00, for a total value of $94,950.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.29% of the stock is currently owned by insiders.

Syneos Health Company Profile (Get Rating)

Syneos Health, Inc provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development.

Read More

Earnings History and Estimates for Syneos Health (NASDAQ:SYNH)

Receive News & Ratings for Syneos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneos Health and related companies with MarketBeat.com's FREE daily email newsletter.